Acyclovir
Product Images NDC 52959-517

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Acyclovir (NDC 52959-517). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Acyclovir (4653f43f B62a 45c2 Bfad Afee9fdc2e12 01)

FDA Label Image

Acyclovir Capsules 200 mg 100s Label (4653f43f B62a 45c2 Bfad Afee9fdc2e12 04)

Acyclovir Capsules  200 mg 100s Label (4653f43f B62a 45c2 Bfad Afee9fdc2e12 04)
This is a description of a drug product identified as 52959-517-30. The product is ACYCLOVIR 200mg capsules manufactured in Toronto, Canada by TEVA PHARM. The lot number and expiry date are ACY200TV and 02/12, respectively. The capsules are RX only and are intended for use to treat a condition similar to Zovirax. The package has a pill identifier for the blue capsule. The dosage should be taken as prescribed by a doctor or by following the usual dosing information found in the outsert provided. There is a caution note which seems to mention allergies "CAUTION. et PROMENS e orr o 1 o oo e e e s o s X i KEP SUPS AR AR S T Gagroe." The rest of the text appears to be lot numbers and codes related to the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.